UBS Group Has Lowered Expectations for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price reduced by analysts at UBS Group from $35.00 to $27.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the medical instruments supplier’s stock. UBS Group’s price objective suggests a potential upside of 38.75% from the company’s current price.

Several other research firms have also issued reports on XRAY. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Needham & Company LLC dropped their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Finally, StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus price target of $28.40.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $19.46 on Tuesday. The firm has a market cap of $3.87 billion, a PE ratio of -9.40, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. The firm’s fifty day moving average is $22.17 and its 200-day moving average is $24.59. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA has a 52 week low of $17.21 and a 52 week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 earnings per share. Sell-side analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently made changes to their positions in XRAY. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in DENTSPLY SIRONA during the third quarter worth about $27,000. LRI Investments LLC boosted its holdings in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new position in DENTSPLY SIRONA during the second quarter worth about $32,000. Finally, Kennebec Savings Bank purchased a new position in DENTSPLY SIRONA during the third quarter worth about $35,000. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.